Antony Pfaffle, Chief Scientific Officer at CorMedix Inc. (CRMD), sold 20,000 shares at $2.23 ($45K) on 2016-10-21, disclosed to the SEC on 2016-10-25.
Scheduled sale ($45k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CRMD | SELL | 2016-06-16 | $11K | — | Filing → |
| CRMD | SELL | 2016-06-14 | $12K | — | Filing → |
| CRMD | SELL | 2016-06-13 | $24K | — | Filing → |